Harmony Biosciences Holdings Inc (HRMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 589,398 | 752,502 | 646,999 | 546,050 | 488,998 |
| Marketable Securities | 51,520 | 22,838 | 25,582 | 19,224 | 17,955 |
| Receivables | 108,222 | 96,787 | 100,651 | 92,981 | 105,969 |
| Inventories | 5,281 | 5,357 | 6,882 | 6,100 | 6,384 |
| Other current assets | 7,595 | 13,516 | 35,378 | 8,636 | 6,916 |
| TOTAL | $778,817 | $907,014 | $838,800 | $691,354 | $642,692 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 1,440 | 1,376 | 1,378 |
| Investments And Advances | 229,555 | 107,127 | 105,831 | 107,008 | 103,245 |
| Intangibles | 83,457 | 89,418 | 95,380 | 101,341 | 107,302 |
| Other Non-Current Assets | 179,995 | 168,072 | 166,767 | 206,929 | 200,918 |
| TOTAL | $493,007 | $364,617 | $369,418 | $416,654 | $412,843 |
| Total Assets | $1,271,824 | $1,271,631 | $1,208,218 | $1,108,008 | $1,055,535 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20,000 | 20,000 | 20,000 | 18,750 | 17,500 |
| Accounts payable and accrued liabilities | 28,600 | 17,693 | 26,341 | 28,301 | 17,459 |
| Accrued Expenses | 156,833 | 209,482 | 176,237 | 130,028 | 120,283 |
| Other current liabilities | 11,907 | 4,957 | 825 | 3,056 | 19,876 |
| TOTAL | $217,340 | $252,132 | $223,403 | $180,135 | $175,118 |
| Non-Current Liabilities | |||||
| Long Term Debt | 138,814 | 143,663 | 148,506 | 153,345 | 158,182 |
| Other Non-Current Liabilities | 5,321 | 5,618 | 1,186 | 1,448 | 1,710 |
| TOTAL | $144,135 | $149,281 | $149,692 | $154,793 | $159,892 |
| Total Liabilities | $361,475 | $401,413 | $373,095 | $334,928 | $335,010 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 57,893 | 57,841 | 57,596 | 57,533 | 57,424 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | 193,391 | 160,903 | 138,417 | 87,552 | 47,776 |
| Other shareholders' equity | -413 | 346 | 357 | 239 | 245 |
| TOTAL | $910,349 | $870,218 | $835,123 | $773,080 | $720,525 |
| Total Liabilities And Equity | $1,271,824 | $1,271,631 | $1,208,218 | $1,108,008 | $1,055,535 |